Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  INC Research Holdings Inc    

INC RESEARCH HOLDINGS INC
Mes dernières consult.
Most popular
  Report  
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Glancy Prongay & Murray LLP : Continues Investigation on Behalf of INC Research Holdings, Inc. Investors (INCR)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/10/2017 | 09:01pm CET

Glancy Prongay & Murray LLP (“GPM”) continues its investigation on behalf of INC Research Holdings, Inc. (“INCR” or the “Company”) (NASDAQ: INCR) investors concerning the Company and its officers’ possible violations of federal securities law. To obtain information or aid in the investigation, please visit the INCR page on our website at https://www.glancylaw.com/case/inc-research-holdings-inc.

On November 9, 2017, INC Research reported its first financial results after combining with inVentiv Health. The Company’s combined results were negatively impacted by merger-related expenses, an impairment charge and increased amortization expenses. The price of INC Research stock fell significantly following the announcement.

On this news, INCR’s stock price fell nearly 30%, or $16.35 per share, to close at $41.15 per share on November 9, 2017, thereby injuring investors.

If you purchased INCR securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley F. Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to [email protected], or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.


© Business Wire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on INC RESEARCH HOLDINGS INC
02/12SYNEOS HEALTH : Names Lisa van Capelle Chief Human Resources Officer
AQ
02/08Syneos Health Names Lisa van Capelle Chief Human Resources Officer
GL
02/06When It Comes to Artificial Intelligence in Healthcare, Patients Fear the Rep..
GL
02/01Syneos Health Schedules Fourth Quarter and Year End 2017 Earnings Call for We..
GL
01/26SYNEOS HEALTH INC : KESSLER TOPAZ MELTZER & CHECK, LLP: Final Deadline Reminder ..
AC
01/25BRAGAR EAGEL & SQUIRE, P.C. : Reminds Investors That a Class Action Lawsuit Has ..
BU
01/23SYNEOS HEALTH INC : KESSLER TOPAZ MELTZER & CHECK, LLP: Important Deadline Remin..
AC
01/22PALIO and GSW to Operate as Singular Advertising Powerhouse Under GSW Brand
GL
01/13SYNEOS HEALTH : Merged INC Research, InVentiv Rebrand as Syneos
AQ
01/11RESEARCH : Syneos Health Releases 2018 Commercial Trends Forecast
AQ
More news
News from SeekingAlpha
01/03INC Research CFO exiting post at April's end 
2017INC Research Holdings 2017 Q3 - Results - Earnings Call Slides 
2017INC Research's (INCR) CEO Alistair MacDonald on Q3 2017 Results - Earnings Ca.. 
2017Midday Gainers / Losers 
2017INC Research misses by $0.08, misses on revenue 
Financials ($)
Sales 2017 3 089 M
EBIT 2017 489 M
Net income 2017 -55,9 M
Debt 2017 2 698 M
Yield 2017 -
P/E ratio 2017 128,00
P/E ratio 2018 38,40
EV / Sales 2017 2,17x
EV / Sales 2018 2,00x
Capitalization 4 007 M
Chart INC RESEARCH HOLDINGS INC
Duration : Period :
INC Research Holdings Inc Technical Analysis Chart | US45329R1095 | 4-Traders
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 12
Average target price 49,7 $
Spread / Average Target 29%
EPS Revisions
Managers
NameTitle
Alistair Macdonald Chief Executive Officer
Kenneth F. Meyers Director
Lisa van Capelle Chief Human Resources Officer
Sector and Competitors
1st jan.Capitalization (M$)
INC RESEARCH HOLDINGS INC-5.39%3 960
CELLTRION, INC.--.--%36 110
IQVIA HOLDINGS INC6.93%21 125
LONZA GROUP-7.82%18 606
INCYTE CORPORATION-6.91%18 063
NEKTAR THERAPEUTICS40.66%13 227